Balyasny Asset Management’s Blueprint Medicines BPMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $64.9M | Buy |
|
|||||
|
2025
Q1 | $5.34M | Sell |
|
|||||
|
2024
Q4 | $8.94M | Buy |
|
|||||
|
2024
Q3 | $2.2M | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $480K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $41.2K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $4.5M | Buy |
|
|||||
|
2021
Q3 | $2.83M | Sell |
|
|||||
|
2021
Q2 | $10.1M | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $14.1M | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $4.46M | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $452K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $20.9M | Buy |
|
|||||
|
2017
Q4 | $3.28M | Sell |
|
|||||
|
2017
Q3 | $6.29M | Buy |
|